Anlotinib Not Yet Recruiting Phase 2 Trials for Extensive-Stage Small Cell Lung Cancer Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03781869Study of Anlotinib as the Maintenance Therapy for Extensive-stage Small Cell Lung Cancer